A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets
Clinical trial NCT03196531 · COMPLETED
Trial details
- NCT number
- NCT03196531
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2018-03-31
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.